Primary anticoagulants
Primary anticoagulants form the basis of the primary anticoagulant system. Their main distinguishing feature is that they are constantly present in the circulating blood. It is thanks to them that blood in intact vessels maintains its rheological properties and does not clot spontaneously.
The most important components of this group include:
- Antithrombins. These are specific proteins that inhibit coagulation proteases. The most significant of these is antithrombin III, which acts as a crucial physiological inhibitor of thrombin.
- Heparin. This substance is actively produced by mast cells and basophils. Heparin has a wide spectrum of action: it inhibits platelet hemostasis and suppresses the activity of most plasma factors, thereby blocking virtually all phases of the coagulation cascade. A critical property of heparin is its ability to dramatically enhance the inhibitory effect of antithrombin III.
- Antithromboplastins. These compounds purposefully inhibit the formation of prothrombinase and block its action, preventing the active phase of coagulation from triggering.
Secondary anticoagulants
Unlike primary anticoagulants, secondary anticoagulants do not circulate in the blood permanently in an active form. They form the secondary anticoagulant system because they are generated directly during the process of blood coagulation and subsequent fibrinolysis. Their physiological task is to restrict thrombus formation strictly to the site of vascular injury and prevent the uncontrolled spread of the thrombus through the bloodstream.
This group includes the following components:
- Fibrin (antithrombin I). Formed as a natural outcome of hemostasis. As it forms a clot, fibrin strands adsorb onto their surface and inactivate up to 90% of all synthesized thrombin, preventing it from acting further.
- Fibrinogen peptides. During fibrin formation, the thrombin molecule cleaves specific peptides from fibrinogen. Once in the plasma, these fragments exhibit a pronounced anticoagulant effect of their own.
- Fibrin and fibrinogen degradation products. They appear at the stage of fibrinolysis (clot dissolution). These are potent anticoagulants that simultaneously work in three directions: they inhibit thrombin, hinder further fibrin formation, and prevent the aggregation of new platelets.
Comparative characteristics of the systems
To better understand how anticoagulant mechanisms work, let us review their key differences in a table:
| Characteristic | Primary system | Secondary system |
|---|---|---|
| Time of appearance | Constantly present in the blood | Generated during hemostasis and fibrinolysis |
| Main function | Maintaining the initial fluid state of blood | Restricting the formed thrombus to the site of vascular injury |
| Key agents | Antithrombin III, heparin, antithromboplastins | Fibrin, fibrinogen peptides, degradation products |
| Relation to thrombin | Direct inhibition (antithrombins) | Adsorption (fibrin) and inhibition by breakdown products |
Briefly: answers to topical questions
Which specific blood coagulation factors does antithrombin III suppress?
Antithrombin III is a blood plasma protein that forms complexes with serine proteases and inactivates them. Sources list its specific targets as:
- thrombin;
- factor IXa;
- factor Xa;
- factor XIIa.
In addition to coagulation factors, targets of antithrombin III also include plasmin and kallikrein. A separate source for antithrombins in general indicates the inhibition of thrombin and factors X, V, and VIII.
What is the anticoagulant role of the vascular endothelium?
The anticoagulant role of the intact vascular endothelium is that it prevents the adhesion of formed blood elements to the wall and participates in restricting thrombus formation.
Endothelium:
- synthesizes prostacyclin (PGI₂) and endothelium-derived relaxing factor (NO), which possess antiplatelet activity; prostacyclin also inhibits the adhesion and aggregation of erythrocytes and platelets;
- expresses/synthesizes tissue factor pathway inhibitor (TFPI), which binds to factor Xa and, as part of a complex, inactivates factor VIIa;
- expresses thrombomodulin on the surface of intact endothelial cells; the thrombin-thrombomodulin complex activates protein C.
Which proteins are part of the protein C anticoagulant system?
Sources directly indicate the following for the protein C anticoagulant system:
- protein C—a plasma protein whose synthesis depends on vitamin K; it is activated by the thrombin-thrombomodulin complex and causes proteolysis of active factors VIIIa and Va, leading to the blockade of thrombin formation;
- protein S—a plasma protein whose synthesis depends on vitamin K; it acts as a cofactor in the proteolytic reaction and enhances the action of protein C.
Thrombomodulin, expressed on the surface of intact endothelial cells, also participates in protein C activation.
For quick memorization of the components of the secondary anticoagulant system, use the "Three Fs" rule: fibrin itself, fibrinogen peptides, and fibrin degradation products.
Class and exam questions
What is the fundamental difference between primary and secondary anticoagulants?
Primary anticoagulants are constantly present in the bloodstream, preventing blood from clotting under normal conditions. Secondary anticoagulants appear only as a consequence of the coagulation process itself or clot dissolution to halt its excessive growth.
How does fibrin stop the coagulation process if it is itself the basis of a thrombus?
Formed fibrin strands act as a potent sorbent (antithrombin I). They absorb and permanently inactivate up to 90% of the generated thrombin, depriving it of the ability to trigger further coagulation.
What is the nature of the synergism between heparin and antithrombin III?
Heparin not only independently inhibits coagulation and platelet hemostasis but also acts as a catalyst: it can dramatically enhance the inhibitory effect of antithrombin III on coagulation factors.
What else to study on this topic
- Mechanisms of inhibition of coagulation system proteases by antithrombin III
- The process of peptide cleavage from the fibrinogen molecule under the action of thrombin
- The role of basophils and mast cells in the synthesis and secretion of endogenous heparin
- The effect of fibrin degradation products on platelet aggregation processes
- Biochemical pathways of blocking prothrombinase formation
Master the entire topic in the "Physiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Anticoagulants" and 4,128 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 114 video lessons on the subject
Other topics in the "Blood" section
Free video lessons: PhysiologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.